JP2002080321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002080321A5 JP2002080321A5 JP2001185774A JP2001185774A JP2002080321A5 JP 2002080321 A5 JP2002080321 A5 JP 2002080321A5 JP 2001185774 A JP2001185774 A JP 2001185774A JP 2001185774 A JP2001185774 A JP 2001185774A JP 2002080321 A5 JP2002080321 A5 JP 2002080321A5
- Authority
- JP
- Japan
- Prior art keywords
- proline
- hydroxyproline
- hydroxy
- cosmetic according
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
【特許請求の範囲】
【請求項１】（１）ヒドロキシプロリンもしくはヒドロキシプロリンのＮ−アシル化誘導体またはその塩と、
（２）水溶性ビタミン、油溶性ビタミン、高分子ペプチド、高分子多糖、スフィンゴ脂質および海草エキスからなる群から選ばれる成分の少なくとも１つとを含有してなる化粧料。
【請求項２】 ヒドロキシプロリンもしくはヒドロキシプロリンのＮ−アシル化誘導体またはその塩を全重量に対し０.０１〜５重量％含有する請求項１記載の化粧料。
【請求項３】 ヒドロキシプロリンが、シス−４−ヒドロキシ−Ｌ−プロリン、シス−４−ヒドロキシ−Ｄ−プロリン、シス−３−ヒドロキシ−Ｌ−プロリン、シス−３−ヒドロキシ−Ｄ−プロリン、トランス−４−ヒドロキシ−Ｌ−プロリン、トランス−４−ヒドロキシ−Ｄ−プロリン、トランス−３−ヒドロキシ−Ｌ−プロリンおよびトランス−３−ヒドロキシ−Ｄ−プロリンからなる群より選ばれるヒドロキシプロリンである、請求項１または２記載の化粧料。
【請求項４】 ヒドロキシプロリンが、微生物により生産されたヒドロキシプロリンである、請求項１〜３のいずれかに記載の化粧料。
【請求項５】 微生物が、アミコラトプシス属、ダクチロスポランジウム属およびストレプトマイセス属から選ばれる属に属する微生物由来のプロリン３位水酸化酵素またはプロリン４位水酸化酵素遺伝子を導入された微生物である、請求項４記載の化粧料。
【請求項６】 ヒドロキシプロリンのＮ−アシル化誘導体のアシル部分が、炭素数２〜２３のアシルである、請求項１または２記載の化粧料。
【請求項７】 ヒドロキシプロリンのＮ−アシル化誘導体が、Ｎ−アセチ化誘導体またはＮ−プロピオニル化誘導体である、請求項１または２記載の化粧料。
【請求項８】 水溶性ビタミン、油溶性ビタミン、高分子ペプチド、高分子多糖、スフィンゴ脂質および海草エキスからなる群から選ばれる成分を全重量に対し０.０００１〜１０重量％含有する請求項１〜７のいずれかに記載の化粧料。
[Claims]
(1) hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof,
(2) A cosmetic comprising at least one component selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular peptides, high molecular polysaccharides, sphingolipids and seaweed extracts.
2. The cosmetic according to claim 1, which contains 0.01 to 5% by weight of hydroxyproline or an N-acylated derivative of hydroxyproline or a salt thereof based on the total weight.
3. Hydroxyproline is cis-4-hydroxy-L-proline, cis-4-hydroxy-D-proline, cis-3-hydroxy-L-proline, cis-3-hydroxy-D-proline, trans A hydroxyproline selected from the group consisting of -4-hydroxy-L-proline, trans-4-hydroxy-D-proline, trans-3-hydroxy-L-proline and trans-3-hydroxy-D-proline. Item 3. The cosmetic according to item 1 or 2.
4. The cosmetic according to claim 1, wherein the hydroxyproline is hydroxyproline produced by a microorganism.
5. The microorganism has a proline 3-hydroxylase or proline 4-hydroxylase gene derived from a microorganism belonging to a genus selected from the genus Amycolatopsis, Dactylosporandium and Streptomyces. The cosmetic according to claim 4, which is a microorganism.
6. The cosmetic according to claim 1, wherein the acyl moiety of the N-acylated derivative of hydroxyproline is an acyl having 2 to 23 carbon atoms.
7. The cosmetic according to claim 1 or 2, wherein the N-acylated derivative of hydroxyproline is an N-acetylated derivative or an N-propionylated derivative.
Claim 8. The composition according to claim 1, further comprising 0.0001 to 10% by weight of a component selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular weight peptides, high molecular weight polysaccharides, sphingolipids and seaweed extract.7The cosmetic according to any one of the above.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001185774A JP2002080321A (en) | 2000-06-20 | 2001-06-20 | Cosmetic |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-183937 | 2000-06-20 | ||
| JP2000183937 | 2000-06-20 | ||
| JP2001185774A JP2002080321A (en) | 2000-06-20 | 2001-06-20 | Cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002080321A JP2002080321A (en) | 2002-03-19 |
| JP2002080321A5 true JP2002080321A5 (en) | 2006-05-18 |
Family
ID=26594240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001185774A Pending JP2002080321A (en) | 2000-06-20 | 2001-06-20 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002080321A (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100652045B1 (en) | 2001-12-21 | 2006-11-30 | 엘지.필립스 엘시디 주식회사 | A Liquid Crystal Display Device And The Method For Manufacturing The Same |
| US6991699B2 (en) | 2002-02-05 | 2006-01-31 | Lg.Philips Lcd Co., Ltd. | LCD bonding machine and method for fabricating LCD by using the same |
| KR100672641B1 (en) | 2002-02-20 | 2007-01-23 | 엘지.필립스 엘시디 주식회사 | Liquid Crystal Display Device and Method of manufacturing the same |
| KR100469508B1 (en) | 2002-02-22 | 2005-02-02 | 엘지.필립스 엘시디 주식회사 | A liquid crystal dispensing apparatus having controlling function of dropping amount caused by controlling tension of spring |
| US6774958B2 (en) | 2002-02-26 | 2004-08-10 | Lg.Philips Lcd Co., Ltd. | Liquid crystal panel, apparatus for inspecting the same, and method of fabricating liquid crystal display thereof |
| US8074551B2 (en) | 2002-02-26 | 2011-12-13 | Lg Display Co., Ltd. | Cutting wheel for liquid crystal display panel |
| US6784970B2 (en) | 2002-02-27 | 2004-08-31 | Lg.Philips Lcd Co., Ltd. | Method of fabricating LCD |
| US6833901B2 (en) | 2002-02-27 | 2004-12-21 | Lg. Philips Lcd Co., Ltd. | Method for fabricating LCD having upper substrate coated with sealant |
| KR100798320B1 (en) | 2002-03-06 | 2008-01-28 | 엘지.필립스 엘시디 주식회사 | Appratus and method for testing liquid crystal display panel |
| KR100685951B1 (en) | 2002-03-06 | 2007-02-23 | 엘지.필립스 엘시디 주식회사 | Liquid Crystal Display Device and Method of manufacturing the same |
| KR100606966B1 (en) | 2002-03-06 | 2006-08-01 | 엘지.필립스 엘시디 주식회사 | Production line of Liquid Crystal Display Device |
| KR100817132B1 (en) | 2002-03-15 | 2008-03-27 | 엘지.필립스 엘시디 주식회사 | Liquid crystal dispensing apparatus |
| JP4210139B2 (en) | 2002-03-23 | 2009-01-14 | エルジー ディスプレイ カンパニー リミテッド | Liquid crystal dropping device capable of adjusting the dropping amount of liquid crystal depending on the height of the spacer and dropping method thereof |
| KR100662496B1 (en) | 2002-03-23 | 2007-01-02 | 엘지.필립스 엘시디 주식회사 | Liquid Crystal Display Device and Method of manufacturing the same |
| KR100518269B1 (en) | 2002-03-25 | 2005-10-04 | 엘지.필립스 엘시디 주식회사 | A method of dispensing liquid crystal using a plurality of liquid crystal dispensing device |
| KR100698040B1 (en) | 2002-06-14 | 2007-03-23 | 엘지.필립스 엘시디 주식회사 | Portable jig |
| US7295279B2 (en) | 2002-06-28 | 2007-11-13 | Lg.Philips Lcd Co., Ltd. | System and method for manufacturing liquid crystal display devices |
| JP4567307B2 (en) * | 2003-08-25 | 2010-10-20 | 株式会社ノエビア | Topical skin preparation |
| JP5424869B2 (en) * | 2007-04-06 | 2014-02-26 | 協和発酵バイオ株式会社 | Skin disinfectant |
| CN102438641B (en) * | 2010-08-06 | 2015-11-25 | 株式会社资生堂 | Elastase inhibitor |
| CN107349125A (en) * | 2012-07-03 | 2017-11-17 | 味之素株式会社 | NMF and the cosmetics containing NMF |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4296099A (en) * | 1976-11-30 | 1981-10-20 | L'oreal | Process for extracting embryonic calf skin and pharmaceutical compositions containing the same |
| FR2503151A1 (en) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use |
| JPS63112506A (en) * | 1986-10-27 | 1988-05-17 | Piasuaraizu Kk | Cosmetic for suppressing dusting |
| JPS63230615A (en) * | 1987-03-20 | 1988-09-27 | Shiseido Co Ltd | Cosmetic |
| FR2619711B1 (en) * | 1987-09-02 | 1991-01-11 | Givaudan La Virotte Cie Ets | COSMETIC APPLICATION OF PROLINE DERIVATIVES, HYDROXYPROLINE AND / OR MIXTURE OF AMINO ACIDS RESULTING FROM COLLAGEN HYDROLYSIS |
| JP2751965B2 (en) * | 1988-04-30 | 1998-05-18 | 川研ファインケミカル株式会社 | Cosmetics |
| FR2632186B1 (en) * | 1988-06-03 | 1992-03-13 | Fabre Pierre Cosmetique | DERMATOCOSMETOLOGICAL COMPOSITIONS FOR THE TREATMENT OF SKIN SENESCENCE AND THE PREVENTION OF WRINKLES |
| JP2810722B2 (en) * | 1989-09-22 | 1998-10-15 | 協和醗酵工業株式会社 | Cosmetics |
| JPH0474108A (en) * | 1990-05-16 | 1992-03-09 | Shin Etsu Chem Co Ltd | Cosmetic |
| ATE117665T1 (en) * | 1990-11-14 | 1995-02-15 | Oreal | AMPHIPHILES, NON-IONIC DERIVATIVES OF GLYCERIN AND THE CORRESPONDING INTERMEDIATE PRODUCTS, METHOD FOR THEIR PRODUCTION AND COMPOSITIONS CONTAINING THEM. |
| JP3132131B2 (en) * | 1991-12-16 | 2001-02-05 | 味の素株式会社 | Bath salts containing amino acids |
| JPH05339140A (en) * | 1992-03-25 | 1993-12-21 | Pola Chem Ind Inc | Skin cosmetic |
| KR950007045B1 (en) * | 1992-04-14 | 1995-06-30 | 주식회사태평양 | Skin cosmetic material containing polyethoxylate vitamin e. |
| JPH0632712A (en) * | 1992-07-13 | 1994-02-08 | Shiseido Co Ltd | Skin external preparation |
| JP3117823B2 (en) * | 1992-11-17 | 2000-12-18 | 鐘紡株式会社 | Collagen metabolic activator |
| JPH06166616A (en) * | 1992-12-01 | 1994-06-14 | Nichirei Corp | Cosmetic |
| JP3492776B2 (en) * | 1993-09-07 | 2004-02-03 | 協和醗酵工業株式会社 | Method for producing cis-3-hydroxy-L-proline |
| JP3122705B2 (en) * | 1993-09-07 | 2001-01-09 | 協和醗酵工業株式会社 | Method for producing trans-4-hydroxy-L-proline |
| JPH0899823A (en) * | 1994-09-29 | 1996-04-16 | Shiseido Co Ltd | Skin external agent |
| JPH0952814A (en) * | 1995-08-09 | 1997-02-25 | Sunstar Inc | Skin cosmetic composition |
| JP3460904B2 (en) * | 1996-04-03 | 2003-10-27 | ライオン株式会社 | External preparation for skin |
| JPH11139951A (en) * | 1997-10-31 | 1999-05-25 | Lion Corp | Cosmetic |
| FR2770777B1 (en) * | 1997-11-10 | 2000-02-25 | Fabre Pierre Dermo Cosmetique | SYNERGISTIC COMPOSITION COMBINING ACS AND / OR DNA WITH HYDROXYPROLINE AND THEIR APPLICATIONS IN NUTRITHERAPY AND COSMETOLOGY |
-
2001
- 2001-06-20 JP JP2001185774A patent/JP2002080321A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002080321A5 (en) | ||
| EP2067487A3 (en) | Immunomodulatory formulations and methods for use thereof | |
| WO2001068144A3 (en) | Biodegradable immunomodulatory formulations and methods for use thereof | |
| EP0784471A4 (en) | Multi-faceted method to repress reproduction of latent viruses in humans and animals | |
| ATE191218T1 (en) | RAPAMYCIN DERIVATIVES AS IMMUNOSUPPRESSORS | |
| AU2003273413A1 (en) | Pharmaceutically active oligosaccharide conjugates | |
| EP1731912A3 (en) | Peptide selection method | |
| EP1935427A3 (en) | Uses of soluble CTLA4 mutant molecules | |
| DE69612198T2 (en) | A VACCINE COMPOSITION CONSISTING OF A POLYSACCHARIDE ANTIGEN CONJUGATE ADDED TO ALUMINUM PHOSPHATE | |
| MY119820A (en) | Guanidine mimics as factor xa inhibitors | |
| AU3884999A (en) | Cosmetic compositions | |
| ATE98290T1 (en) | DIFLUOROMETHYL COMPOUNDS. | |
| EP1880735A3 (en) | Vaccine | |
| CA2223567A1 (en) | Modified meningococcal polysaccharide conjugate vaccines | |
| AU6114699A (en) | Naphthrydine compounds and their azaisosteric analogues as antibacterials | |
| AU6357900A (en) | Hyaluronic acid-protein conjugates, pharmaceutical compositions and related methods | |
| CA2229271A1 (en) | Compositions containing hydroxy acids or retinoids | |
| AU6799000A (en) | Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or pro-ms immune response | |
| AU4871797A (en) | Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it | |
| EP1064909A3 (en) | High internal aqueous phase water-in-oil type emulsion cosmetic composition | |
| CA2261579A1 (en) | Isolated peptides derived from mage-2 | |
| MY125051A (en) | Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an hmg-coa-reductase inhibitor | |
| AU2307695A (en) | High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base | |
| AU3252197A (en) | Novel self-acid-doped highly conducting polythiophenes | |
| AU4651700A (en) | Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |